Analysis of the Usefulness of the WORSEN Score for Predicting the Deterioration of Acute Ischemic Stroke

J Stroke Cerebrovasc Dis. 2017 Dec;26(12):2834-2839. doi: 10.1016/j.jstrokecerebrovasdis.2017.07.005. Epub 2017 Aug 4.

Abstract

Background: Early neurological worsening is associated with increased mortality and long-term functional disability. We developed the WORSEN score for predicting whether patients with stroke will deteriorate during the week after stroke onset and investigated its usefulness.

Patients and methods: We retrospectively investigated the cases of 478 patients who were admitted to Juntendo University Hospital between April 2007 and March 2009. Neurological deterioration was defined as a worsening of 4 points or higher on the National Institute of Health Stroke Scale score within 1 week of admission. Based on a previous study, we developed the WORSEN score, which was derived from the following factors: wrong (poor) blood sugar control (W), old myocardial infarction (O), radiological findings (R), infarct size (S), elevated low-density lipoprotein cholesterol (E), and neurological findings (N). Next, we investigated the utility of this scoring system in 456 other patients who were admitted to Juntendo University Hospital and Juntendo Urayasu Hospital between October 2013 and December 2014.

Results: First, we checked the utility of the WORSEN score for detecting worsening in cases of stroke. In the first patient group, deterioration was noted in 32.5% of the patients with scores higher than 3 points (sensitivity: .704 and specificity: .744). For checking reproductivity on using the second group, deterioration was detected in 36.1% of the patients with WORSEN scores higher than 3 points (sensitivity: .740 and specificity: .835).

Conclusions: Careful attention should be paid to patients with acute stroke with high WORSEN scores. The WORSEN score might become a valuable tool for detecting the neurological deterioration of ischemic stroke.

Keywords: Acute ischemic stroke; diabetes; dyslipidemia; history of myocardial infarction; neurological deterioration.

Publication types

  • Evaluation Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Blood Glucose / metabolism
  • Brain Ischemia / blood
  • Brain Ischemia / diagnosis*
  • Brain Ischemia / physiopathology
  • Cholesterol, LDL / blood
  • Decision Support Techniques*
  • Disability Evaluation*
  • Disease Progression
  • Female
  • Hospitals, University
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnosis
  • Nerve Degeneration
  • Predictive Value of Tests
  • Prognosis
  • Reproducibility of Results
  • Retrospective Studies
  • Risk Factors
  • Stroke / blood
  • Stroke / diagnosis*
  • Stroke / physiopathology
  • Time Factors

Substances

  • Biomarkers
  • Blood Glucose
  • Cholesterol, LDL